Orla Kjær-Christensen
Career history of Orla Kjær-Christensen
Former positions of Orla Kjær-Christensen
| Companies | Position | Start | End |
|---|---|---|---|
Sparekassen Himmerland A/S
 Sparekassen Himmerland A/S Regional BanksFinance Sparekassen Himmerland A/S is engaged in the provision of financial and banking services. It offers financial products and services to both private and corporate clients including pension, insurance, cash management, and investment management. The company was founded in December 14, 1871 and is headquartered in Aars, Denmark. | Sales & Marketing | - | 2014-01-08 |
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Director/Board Member | 2007-12-31 | - |
| Chief Operating Officer | 2007-12-31 | - |
Training of Orla Kjær-Christensen
| University of Tromso | Doctorate Degree |
Statistics
International
| Norway | 3 |
| Denmark | 2 |
Operational
| Sales & Marketing | 1 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Sparekassen Himmerland A/S
Sparekassen Himmerland A/S Regional BanksFinance Sparekassen Himmerland A/S is engaged in the provision of financial and banking services. It offers financial products and services to both private and corporate clients including pension, insurance, cash management, and investment management. The company was founded in December 14, 1871 and is headquartered in Aars, Denmark. | Finance |
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
